Browsing by Subject "Prostatic neoplasms"
Now showing 1 - 2 of 2
- Results Per Page
- Sort Options
Item Open Access System for prostate brachytherapy and biopsy in a standard 1.5 T MRI scanner(John Wiley & Sons, 2004) Susil, R.C.; Camphausen, K.; Choyke, P.; McVeigh, E. R.; Gustafson, G. S.; Ning, H.; Miller, R. W.; Atalar, Ergin; Coleman, C. N.; Ménard, C.A technique for transperineal high-dose-rate (HDR) prostate brachytherapy and needle biopsy in a standard 1.5 T MRI scanner is demonstrated. In each of eight procedures (in four patients with intermediate to high risk localized prostate cancer), four MRI-guided transperineal prostate biopsies were obtained followed by placement of 14-15 hollow transperineal catheters for HDR brachytherapy. Mean needle-placement accuracy was 2.1 mm, 95% of needle-placement errors were less than 4.0 mm, and the maximum needle-placement error was 4.4 mm. In addition to guiding the placement of biopsy needles and brachytherapy catheters, MR images were also used for brachytherapy treatment planning and optimization. Because 1.5 T MR images are directly acquired during the interventional procedure, dependence on deformable registration is reduced and online image quality is maximized.Item Open Access Transrectal prostate biopsy and fiducial marker placement in a standard 1.5T magnetic resonance imaging scanner(Elsevier Inc., 2006-01) Susil, R. C.; Menard, C.; Kriegel, A.; Coleman, J. A.; Camphausen, K.; Choyke, P.; Fichtinger, G.; Whitcomb, L. L.; Coleman, C. N.; Atalar, ErginPurpose: We investigated the accuracy and feasibility of a system that provides transrectal needle access to the prostate concurrent with 1.5 Tesla MRI which previously has not been possible. Materials and Methods: In 5 patients with previously diagnosed prostate cancer, MRI guided intraprostatic placement of gold fiducial markers (4 procedures) and/or prostate biopsy (3 procedures) was performed using local anesthesia. Results: Mean procedure duration was 76 minutes and all patients tolerated the intervention well. Procedure related adverse events included self-limited hematuria and hematochezia following 3 of 8 procedures (all resolved in less than 1 week). Mean needle placement accuracy was 1.9 mm for the fiducial marker placement studies and 1.8 mm for the biopsy procedures. Mean fiducial marker placement accuracy was 4.8 mm and the mean fiducial marker placement accuracy transverse to the needle direction was 2.6 mm. All patients who underwent the procedure were able to complete their course of radiotherapy without delay or complication. Conclusions: While studies of clinical usefulness are warranted, transrectal 1.5 T MRI guided prostate biopsy and fiducial marker placement is feasible using this system, providing new opportunities for image guided diagnostic and therapeutic prostate interventions.